Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/23/2026
- Wall St falls as Big Tech earnings rekindle AI spending worries; oil hits $100
- Google increases capex forecast again after cloud-driven quarterly beat
- As Musk pivots beyond cars, Tesla’s autos engine is under strain
- RTX stock jumps as company lifts guidance after Q2 beat
- Dollar hits new 40-year high versus yen, euro lower after ECB decision
Juniper Pharma (JNP) Misses Q1 EPS by 9c
May 6, 2015 7:16 AM EDTJuniper Pharma (NASDAQ: JNP) reported Q1 EPS of ($0.06), $0.09 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $8.3 million versus the consensus estimate of $7.8 million.
Adjusted EBITDA was $0.4 million in the first quarter of 2015 compared with $0.5 million in the first quarter of... More
